Baxter International Inc (BAX)

$19.91 +0.04 (0.20%)
Market Cap 10.32B
Revenue (ttm) 10.64B
Net Income (ttm) -649.00M
EPS (ttm) N/A
PE Ratio 8.19
Forward PE 8.51
Profit Margin -6.10%
Debt to Equity Ratio 1.32
Volume 8,000,100
Avg Vol 8,214,704
Day's Range N/A - N/A
Shares Out 514.06M
Stochastic %K 56%
Beta 0.59
Analysts Sell
Price Target $21.54

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed sy...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 224 948 2000
Address:
One Baxter Parkway, Deerfield, United States
OptionSamurai
OptionSamurai Feb. 2 at 4:09 PM
A new candidate for a wheel strategy on our screener: $BAX 💵 Company has a fundamental score of 9 and a growth score of 5. 📈 IV percentile is 89.3% 🔮 Annualized covered call return is 56.6% You can sell a put strike 17.5 (4.5 ATRs away) for 20-Feb-26 ✅ Return is 1.4% and 29.1% annualized ✅ Breakeven is 13.7% away ✅ Dividend yield if assigned is 4.1% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Andrewfritzen01
Andrewfritzen01 Jan. 30 at 6:22 AM
$BAX easy long adds all year
0 · Reply
OnlyFibs
OnlyFibs Jan. 30 at 2:18 AM
$BAX accumulation is real and it’s beautiful! 😍📈 Sitting at $19.74, trading at a ridiculous 8x forward P/E. No cap, the market is pricing this medtech giant like it’s going out of style, but $2.6B in free cash flow says otherwise. CEO Andrew Hider’s turnaround plan is starting to stick. 🛠️ 🐂 Bulls: Looking to flip $20.00 and run to that $21.40 analyst target. 🐻 Bears: Still crying about the dividend cut. If $18.97 breaks, the accumulation is cooked. Key levels to confirm: ✅ Over $20.11 to confirm the breakout ❌ Below $18.97 for a failed base signal #hovdid $BAX #MedTech #ValueInvesting #Trading #Dividends
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 1:34 PM
$BAX losing ground — is it time to worry? 🧐 Shares down 31.4% in six months, outpacing the industry’s 10.7% decline, with operational challenges like prolonged Novum infusion pump disruptions weighing heavy. Yet, there’s potential in its Healthcare Systems & Technologies contributing as a stabilizer as cost headwinds normalize. Full analysis here 👉 https://www.zacks.com/stock/news/2824086/reasons-to-retain-baxter-international-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2824086-body-30606&ADID=SYND_STOCKTWITS_TWEET_2_2824086_BODY_30606
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 12:34 PM
Why $BAX still deserves a spot in your portfolio 🧐 The company is reshaping its portfolio after divesting its Kidney Care business, sharpening its focus on surgical strength while prioritizing deleveraging and tighter execution to rebuild momentum. Discover the key reasons to retain the stock here 👉 https://www.zacks.com/stock/news/2824086/reasons-to-retain-baxter-international-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2824086-teaser-30602&ADID=SYND_STOCKTWITS_TWEET_2_2824086_TEASER_30602
0 · Reply
LIVELOVELAUGHLEARN
LIVELOVELAUGHLEARN Jan. 27 at 3:21 PM
$BAX they a dumb Brazilian CEO for way too long who destroyed the organization. Wish they fired him long ago.
0 · Reply
OptionSamurai
OptionSamurai Jan. 26 at 4:04 PM
A new candidate for a wheel strategy on our screener: $BAX 💵 Company has a fundamental score of 9 and a growth score of 5. 📈 IV percentile is 90.1% 🔮 Annualized covered call return is 51.0% You can sell a put strike 17.5 (3.7 ATRs away) for 20-Feb-26 ✅ Return is 1.7% and 25.3% annualized ✅ Breakeven is 12.8% away ✅ Dividend yield if assigned is 4.1% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Gemineye
Gemineye Jan. 21 at 6:38 PM
$BAX https://archive.fast-edgar.com/20260121/ALZSK22CT222G2Z2222P22ZTMBBTZ2282282/
0 · Reply
Xplode
Xplode Jan. 21 at 4:02 PM
$BAX second large order buy I’ve seen in the last 15 minutes
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 20 at 1:47 AM
$BAX RSI: 57.26, MACD: 0.3038 Vol: 0.66, MA20: 19.72, MA50: 18.96 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on BAX
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

Jan 21, 2026, 5:00 PM EST - 13 days ago

Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

The Bottom Fishing Club - Baxter: Defensive Pick, Restructuring And Paying Down Debt

Jan 17, 2026, 7:11 AM EST - 17 days ago

The Bottom Fishing Club - Baxter: Defensive Pick, Restructuring And Paying Down Debt

Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Jan 13, 2026, 9:00 AM EST - 21 days ago

Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 8:26 PM EST - 22 days ago

Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

Jan 8, 2026, 9:00 AM EST - 26 days ago

MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

Baxter to Present at J.P. Morgan 2026 Healthcare Conference

Jan 6, 2026, 5:14 PM EST - 4 weeks ago

Baxter to Present at J.P. Morgan 2026 Healthcare Conference

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International and Molina Healthcare on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Dec 16, 2025, 4:30 PM EST - 7 weeks ago

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International and Molina Healthcare on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

MOH

DOC HOLLYWOOD: A Psychiatrist Takes 3rd Place with Baxter's Brain at the American Film Market Pitch Conference

Dec 12, 2025, 10:32 AM EST - 7 weeks ago

DOC HOLLYWOOD: A Psychiatrist Takes 3rd Place with Baxter's Brain at the American Film Market Pitch Conference

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Dec 11, 2025, 10:21 AM EST - 7 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity

Dec 11, 2025, 8:30 AM EST - 7 weeks ago

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity

Scrooge: 5 Stocks That Could Ruin Your Santa Rally

Dec 10, 2025, 1:00 PM EST - 7 weeks ago

Scrooge: 5 Stocks That Could Ruin Your Santa Rally

AXON BAH SG WLK

BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Dec 8, 2025, 12:49 PM EST - 2 months ago

BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Macquarie Value Fund Q3 2025 Sales And Purchases

Dec 7, 2025, 2:11 PM EST - 2 months ago

Macquarie Value Fund Q3 2025 Sales And Purchases

ALL CAG DIS MRSH PLD PPG WFC

Bragar Eagel & Squire, P.C. Reminds James Hardie and Baxter International Investors to Contact the Firm Regarding Their Rights

Dec 4, 2025, 6:07 PM EST - 2 months ago

Bragar Eagel & Squire, P.C. Reminds James Hardie and Baxter International Investors to Contact the Firm Regarding Their Rights

JHX

Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Dec 4, 2025, 4:15 PM EST - 2 months ago

Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Dec 4, 2025, 7:51 AM EST - 2 months ago

Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 2, 2025, 3:23 PM EST - 2 months ago

Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Dec 1, 2025, 5:56 PM EST - 2 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Artisan Value Income Fund Q3 2025 Contributors And Detractors

Nov 24, 2025, 10:56 AM EST - 2 months ago

Artisan Value Income Fund Q3 2025 Contributors And Detractors

LRCX NVT PII PM

Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

Nov 19, 2025, 4:15 PM EST - 2 months ago

Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

Baxter Announces Tender Offers for 2026 Notes and 2027 Notes

Nov 19, 2025, 8:54 AM EST - 2 months ago

Baxter Announces Tender Offers for 2026 Notes and 2027 Notes

Baxter International Inc. (BAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 10:28 AM EST - 2 months ago

Baxter International Inc. (BAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Baxter Declares Quarterly Dividend

Nov 11, 2025, 4:30 PM EST - 3 months ago

Baxter Declares Quarterly Dividend

BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline

Nov 10, 2025, 8:15 AM EST - 3 months ago

BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline

The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

Nov 7, 2025, 8:45 AM EST - 3 months ago

The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit – BAX

Nov 5, 2025, 6:00 PM EST - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit – BAX

Watch These Stocks Falling 10% Or More

Nov 4, 2025, 4:58 PM EST - 3 months ago

Watch These Stocks Falling 10% Or More

AJG ARE BRO CAVA CMG DECK ERIE

Don't Write Off Baxter Just Yet

Nov 4, 2025, 8:30 AM EST - 3 months ago

Don't Write Off Baxter Just Yet

Baxter Trims Annual Outlook Again, Stock Hits 52-Week

Oct 30, 2025, 2:54 PM EDT - 3 months ago

Baxter Trims Annual Outlook Again, Stock Hits 52-Week

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Oct 30, 2025, 11:29 AM EDT - 3 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Baxter International Inc. (BAX) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 11:26 AM EDT - 3 months ago

Baxter International Inc. (BAX) Q3 2025 Earnings Call Transcript

Medical products maker Baxter cuts annual profit forecast on persistent hurricane impact

Oct 30, 2025, 8:27 AM EDT - 3 months ago

Medical products maker Baxter cuts annual profit forecast on persistent hurricane impact

Baxter Reports Third-Quarter 2025 Results

Oct 30, 2025, 7:15 AM EDT - 3 months ago

Baxter Reports Third-Quarter 2025 Results

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Oct 28, 2025, 9:38 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

OptionSamurai
OptionSamurai Feb. 2 at 4:09 PM
A new candidate for a wheel strategy on our screener: $BAX 💵 Company has a fundamental score of 9 and a growth score of 5. 📈 IV percentile is 89.3% 🔮 Annualized covered call return is 56.6% You can sell a put strike 17.5 (4.5 ATRs away) for 20-Feb-26 ✅ Return is 1.4% and 29.1% annualized ✅ Breakeven is 13.7% away ✅ Dividend yield if assigned is 4.1% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Andrewfritzen01
Andrewfritzen01 Jan. 30 at 6:22 AM
$BAX easy long adds all year
0 · Reply
OnlyFibs
OnlyFibs Jan. 30 at 2:18 AM
$BAX accumulation is real and it’s beautiful! 😍📈 Sitting at $19.74, trading at a ridiculous 8x forward P/E. No cap, the market is pricing this medtech giant like it’s going out of style, but $2.6B in free cash flow says otherwise. CEO Andrew Hider’s turnaround plan is starting to stick. 🛠️ 🐂 Bulls: Looking to flip $20.00 and run to that $21.40 analyst target. 🐻 Bears: Still crying about the dividend cut. If $18.97 breaks, the accumulation is cooked. Key levels to confirm: ✅ Over $20.11 to confirm the breakout ❌ Below $18.97 for a failed base signal #hovdid $BAX #MedTech #ValueInvesting #Trading #Dividends
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 1:34 PM
$BAX losing ground — is it time to worry? 🧐 Shares down 31.4% in six months, outpacing the industry’s 10.7% decline, with operational challenges like prolonged Novum infusion pump disruptions weighing heavy. Yet, there’s potential in its Healthcare Systems & Technologies contributing as a stabilizer as cost headwinds normalize. Full analysis here 👉 https://www.zacks.com/stock/news/2824086/reasons-to-retain-baxter-international-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2824086-body-30606&ADID=SYND_STOCKTWITS_TWEET_2_2824086_BODY_30606
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 12:34 PM
Why $BAX still deserves a spot in your portfolio 🧐 The company is reshaping its portfolio after divesting its Kidney Care business, sharpening its focus on surgical strength while prioritizing deleveraging and tighter execution to rebuild momentum. Discover the key reasons to retain the stock here 👉 https://www.zacks.com/stock/news/2824086/reasons-to-retain-baxter-international-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2824086-teaser-30602&ADID=SYND_STOCKTWITS_TWEET_2_2824086_TEASER_30602
0 · Reply
LIVELOVELAUGHLEARN
LIVELOVELAUGHLEARN Jan. 27 at 3:21 PM
$BAX they a dumb Brazilian CEO for way too long who destroyed the organization. Wish they fired him long ago.
0 · Reply
OptionSamurai
OptionSamurai Jan. 26 at 4:04 PM
A new candidate for a wheel strategy on our screener: $BAX 💵 Company has a fundamental score of 9 and a growth score of 5. 📈 IV percentile is 90.1% 🔮 Annualized covered call return is 51.0% You can sell a put strike 17.5 (3.7 ATRs away) for 20-Feb-26 ✅ Return is 1.7% and 25.3% annualized ✅ Breakeven is 12.8% away ✅ Dividend yield if assigned is 4.1% 🔥 See more results & create your own scan here: https://bit.ly/3lR1xIP
0 · Reply
Gemineye
Gemineye Jan. 21 at 6:38 PM
$BAX https://archive.fast-edgar.com/20260121/ALZSK22CT222G2Z2222P22ZTMBBTZ2282282/
0 · Reply
Xplode
Xplode Jan. 21 at 4:02 PM
$BAX second large order buy I’ve seen in the last 15 minutes
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 20 at 1:47 AM
$BAX RSI: 57.26, MACD: 0.3038 Vol: 0.66, MA20: 19.72, MA50: 18.96 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ajoe1
ajoe1 Jan. 18 at 2:04 AM
$BAX this is such a great longer term buy.
0 · Reply
ZacksResearch
ZacksResearch Jan. 14 at 5:42 PM
$BAX unveils Dynamo Series smart stretcher — innovation or a missed opportunity? 🤔 Despite the launch, BAX shares stayed flat in after-market trading. The stock is down 31.1% over six months, underperforming the industry’s 7.2% decline and the S&P 500’s 14.4% rise. Full analysis here 👉 https://www.zacks.com/stock/news/2817415/baxter-unveils-dynamo-smart-stretcher-to-improve-hospital-safety?cid=sm-stocktwits-2-2817415-body-28919&ADID=SYND_STOCKTWITS_TWEET_2_2817415_BODY_28919
0 · Reply
ZacksResearch
ZacksResearch Jan. 14 at 4:42 PM
Hospital safety upgrade — and a quiet efficiency play for $BAX 🏥 Baxter just unveiled its Dynamo Series smart stretcher, designed to improve hospital safety and reduce the need for patient transfers — targeting a real operational pain point in care settings. See how this product could impact Baxter’s healthcare footprint 👉 https://www.zacks.com/stock/news/2817415/baxter-unveils-dynamo-smart-stretcher-to-improve-hospital-safety?cid=sm-stocktwits-2-2817415-teaser-28904&ADID=SYND_STOCKTWITS_TWEET_2_2817415_TEASER_28904
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 13 at 7:52 PM
$BAX Share Price: $19.72 Contract Selected: Feb 06, 2026 $20 Calls Buy Zone: $0.47 – $0.58 Target Zone: $0.76 – $0.93 Potential Upside: 54% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
DollarFlipper
DollarFlipper Jan. 13 at 6:47 PM
$BAX
0 · Reply
TeresaTrades
TeresaTrades Jan. 13 at 2:17 PM
Largest PUT OI increases $HTZ $BAX $WEN $ALIT $SMR
0 · Reply
FLTR8R
FLTR8R Jan. 12 at 11:31 PM
$BAX When news of pump issues resolved, we'll wake up and this bitch will be trading $30 and no looking back... Watch and learn folks!
0 · Reply
UmmHmmDaddy
UmmHmmDaddy Jan. 12 at 7:27 PM
$BAX premium trash
0 · Reply
anachartanalyst
anachartanalyst Jan. 9 at 3:02 PM
$BAX https://anachart.com/wp-content/uploads/ana_temp/1767970897_soc-img.jpg
0 · Reply
CapitalMonk
CapitalMonk Jan. 9 at 2:42 PM
$BAX Price: $20.99 (+1.45%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.80% RSI: 80.2 | Momentum: Moderate Volume: -89.9% vs avg Volatility: 1.55% Support: $18.25 | Resistance: $21.07 Powered by: ALDS
0 · Reply
dred48
dred48 Jan. 6 at 2:41 PM
$BAX bax awake
0 · Reply
jelu77
jelu77 Jan. 6 at 12:55 AM
$BAX Turnaround management actions are ongoing, and temporary hiccups are being addressed.
0 · Reply